Ultragenyx Pharma (RARE) PT Lowered to $70 at Wedbush
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $22.41 +2.89%
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $70.00 (from $72.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- BorgWarner (BWA) PT Raised to $95 at Wolfe Research, 'Bullish Takeaways from CEO Meetings'
- Medtronic, Inc. (MDT) PT Lowered to $101 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
